Company Monitoring Page for Achillion

latest headlines for company on cafepharma

Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
Tags:
hepatitis C, Achillion, Gilead, Idenix, Merck, Medivir, Vertex Pharmaceuticals
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Sat, 11/24/12 - 12:01 pm
Tags:
Gilead Sciences, sofosbuvir, hepatitis C, Bristol-Myers Squibb, BMS-986094, Idenix, IDX-184, Abbott Laboratories, Achillion, ACH-3102
Has Achillion Pharmaceuticals Become the Perfect Stock?
Motley Fool
Sat, 11/24/12 - 11:39 am
Tags:
Achillion
This Week in Biotech: Part 1 (The Hep-C Chronicles)
Motley Fool
Sat, 11/17/12 - 01:47 pm
Tags:
Gilead Sciences, Abbott Laboratories, Idenix, Achillion, hepatitis C
Does Achillion Have a Place in the HCV Market of the Future?
Yahoo/Reuters
Wed, 11/14/12 - 12:30 pm
Tags:
Achillion, hepatitis C, Abbott Labs, Gilead, ACH-1625, Vertex Pharmaceuticals
3 Reasons Why Not All Hep C Data Is Created Equal
Motley Fool
Tue, 11/13/12 - 11:51 am
Tags:
hepatitis C, Gilead, Abbott Labs, Vertex Pharmaceuticals, Achillion, Idenix
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
Tags:
biotech, M&A, Amarin, Achillion, ONYX Pharmaceuticals, Actelion, Elan, Forest Labs, Medivation, Biomarin, Indenix
For Hep C Investors, What Goes Around Comes Around
Motley Fool
Sat, 11/3/12 - 11:28 am
Tags:
hepatitis C, Vertex Pharmaceuticals, Gilead Sciences, Abbott Laboratories, Idenix, Achillion
BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment
Yahoo/Fly on the Wall
Thu, 10/18/12 - 01:10 pm
Tags:
Biocryst, Presidio, hepatitis C, M&A, Gilead, Abbott Labs, Achillion
[video] The Next Big Thing in Biotech: Hepatitis Drugs
TheStreet.com
Fri, 09/28/12 - 10:18 am
Tags:
hepatitis C, Abbott Labs, Gilead Sciences, JNJ, Merck, Vertex Pharmaceuticals, Idenix, Achillion
Achillion Announces Positive Proof-of-Concept Data With ACH-3102
Yahoo
Thu, 09/27/12 - 10:51 am
Tags:
ACH-3102, Achillion
Achillion Pharma draws bullish bet
Yahoo/optionMONSTER
Tue, 09/25/12 - 04:01 pm
Tags:
Achillion
Achillion Back On The Hep C Roller Coaster Of Love
Seeking Alpha
Wed, 09/19/12 - 11:30 am
Tags:
Achillion, hepatitis C, Abbott Labs, Gilead, JNJ, Merck, Pfizer, ACH-1625
7 Rallying Biotech Stocks Being Snapped Up By Hedge Funds
Seeking Alpha
Sat, 09/15/12 - 09:30 am
Tags:
Achillion, Affymax, Alexion, Jazz Pharmaceuticals, ONYX Pharmaceuticals, Threshold Pharmaceuticals, ViroPharma
Achillion announces SVR4 of 85%-100% from trial evaluating sovaprevir
Yahoo/Fly on the Wall
Tue, 08/7/12 - 05:56 pm
Tags:
Achillion, sovaprevir, hepatitis C
Insiders Bought 3 Plunging Healthcare Stocks Last Week, And 3 Other Noteworthy Buys And 5 Sells
Seeking Alpha
Sat, 06/16/12 - 01:54 pm
Tags:
Achillion, Allscripts, Targacept, Endo, United Therapeutics, Nanosphere
Achillion jumps on hepatitis C study
Marketwatch
Mon, 05/21/12 - 04:49 pm
Tags:
Achillion, hepatitis C, ACH-2684
Achillion's hepatitis C drug gets FDA fast track
Reuters
Tue, 05/15/12 - 12:11 pm
Tags:
Achillion, hepatitis C, fast track, FDA, ACH-3102
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Tags:
Vertex, Incivek, ABT-072, ABT-450, Abbott Laboratories, Achillion, ACH-1625, ACH-2684, ACH-2928, ACH-3102, TMC435, JNJ, GSK, hepatitis C
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
Yahoo/Globe NewsWire
Sat, 04/21/12 - 12:05 pm
Tags:
Achillion, ACH-1625, ACH-3102, ACH-2928, hepatitis C

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.